New FTC Homeopathy Marketing Claims Policy

  • Context: News 
  • Thread starter Thread starter Drakkith
  • Start date Start date
  • Tags Tags
    Marketing
Click For Summary

Discussion Overview

The discussion centers around the recent enforcement policy statement issued by the U.S. Federal Trade Commission (FTC) regarding marketing claims for over-the-counter homeopathic drugs. Participants explore the implications of this policy on consumer protection, regulatory practices, and the efficacy of homeopathic products.

Discussion Character

  • Debate/contested
  • Conceptual clarification

Main Points Raised

  • Some participants express that the FTC's new policy is a positive step towards regulating homeopathic products and protecting consumers from misleading claims.
  • Others highlight the loophole in the policy that allows homeopathic products to be marketed with disclaimers about the lack of scientific evidence, suggesting that this may not effectively prevent consumer deception.
  • One participant notes the tragic consequences that have arisen from the use of homeopathic products, implying that regulatory action was prompted by serious health risks.
  • Another participant comments on the persistent consumer demand for homeopathic products, despite their lack of scientific backing, indicating a skepticism about the effectiveness of regulatory measures.
  • A later reply raises concerns about potential legislative actions that could undermine the FTC's new regulations, referencing Congress's ability to nullify recent regulations under the Congressional Review Act.

Areas of Agreement / Disagreement

Participants generally agree that the FTC's policy is a step in the right direction, but there is significant disagreement regarding its effectiveness and the potential for future legislative actions that may counteract these regulations.

Contextual Notes

Participants express concerns about the implications of consumer literacy in understanding the disclaimers associated with homeopathic products and the potential for regulatory rollback due to political actions.

Drakkith
Mentor
Messages
23,202
Reaction score
7,685
FTC Issues Enforcement Policy Statement Regarding Marketing Claims for Over-the-Counter Homeopathic Drugs

The U.S. FTC (Federal Trade Commission) dealt a possibly big blow to homeopathic companies a few days ago. After spending the last year or so reviewing their policies regarding homeopathic products, the FTC finally released a statement on November 15th. Here's the main article: https://www.ftc.gov/news-events/pre...orcement-policy-statement-regarding-marketing

The Federal Trade Commission today announced a new “Enforcement Policy Statement on Marketing Claims for Over-the-Counter (OTC) Homeopathic Drugs.” The policy statement was informed by an FTC workshop held last year to examine how such drugs are marketed to consumers. The FTC also released its staff report on the workshop, which summarizes the panel presentations and related public comments in addition to describing consumer research commissioned by the FTC.

The policy statement explains that the FTC will hold efficacy and safety claims for OTC homeopathic drugs to the same standard as other products making similar claims. That is, companies must have competent and reliable scientific evidence for health-related claims, including claims that a product can treat specific conditions. The statement describes the type of scientific evidence that the Commission requires of companies making such claims for their products.

While this is absolutely good news, the new policies still provide a loophole of sorts:

However, the policy statement also notes that “the FTC has long recognized that marketing claims may include additional explanatory information to prevent the claims from being misleading. Accordingly, it recognizes that an OTC homeopathic drug claim that is not substantiated by competent and reliable scientific evidence might not be deceptive if the advertisement or label where it appears effectively communicates that: 1) there is no scientific evidence that the product works; and 2) the product’s claims are based only on theories of homeopathy from the 1700s that are not accepted by most modern medical experts.

Basically this means that homeopathic products can continue to be sold with the appropriate labeling mentioned above. So in the end we're still relying on the consumer being scientifically literate enough to recognize a bad product if the label says, "There is no scientific evidence supporting the efficacy of this product."

The FDA has also been reviewing their policies but has not yet released a statement.

Another article on this: https://www.sciencebasedmedicine.org/ftc-homeopathy-win/
 
  • Like
Likes   Reactions: DrClaude, Evo and Greg Bernhardt
Biology news on Phys.org
Moving in the right direction. I've seen too many people get fleeced.
 
  • Like
Likes   Reactions: Evo
Yeah, and all it took to motivate the regulators was a few dead babies! NBD!
 
  • Like
Likes   Reactions: Dembadon and Evo
And still people will buy the stuff, even though it's just water.
 
  • Like
Likes   Reactions: Dembadon and Drakkith
Don't get your hopes up. Just in , Congress intends to pass a http://www.msn.com/en-us/news/politics/trump-scores-his-first-win-in-congress/ar-AAkpQJx?li This will allow Trump to get money into his programs in the 2017 budget. This will also allow the congress to break early and give them an opportunity to exercise the Congressional Review Act that allows them to nullify regulations approved within the last 60 legislative days. This now extends back to May because of so many breaks this year. On the docket for nullification are significant changes in the food labeling regulations.
 

Similar threads

  • · Replies 16 ·
Replies
16
Views
50K
  • · Replies 10 ·
Replies
10
Views
4K
Replies
2
Views
2K
  • · Replies 9 ·
Replies
9
Views
4K
Replies
40
Views
11K
  • · Replies 21 ·
Replies
21
Views
5K
Replies
12
Views
3K
  • · Replies 3 ·
Replies
3
Views
4K
  • · Replies 38 ·
2
Replies
38
Views
8K
  • · Replies 31 ·
2
Replies
31
Views
6K